疏血通注射液治疗肺间质纤维化20例临床观察

Clinical Observation on Treating 20 Cases of Pulmonary Interstitial Fibrosis with Shuxuetong Injection

[目的]观察疏血通注射液治疗肺间质纤维化的临床疗效。[方法]将35例患者随机分为两组。对照组15例采用抗感染、解痉平喘、止咳、化痰、持续或间断低流量吸氧及对症处理,治疗组20例在对照组治疗基础上加用疏血通注射液静脉滴注,1次/d。经过1个疗程(15d)治疗后观察两组治疗前后临床症状、体征及实验室检测结果的改善情况。[结果]治疗组显效8例,有效9例,无效3例,总有效率85.00%;对照组显效3例,有效6例,无效6例,总有效率60.00%。临床疗效治疗组优于对照组(P<0.05)。[结论]疏血通注射液治疗特发性肺间质纤维化疗效显著。

[Objective]To observe clinical effect of treating pulmonary interstitial fibrosis with Shuxuetong injection.[Method]The 35 cases were randomly divided into two groups,Control group 15 cases with anti-inflammatory,antispasmodic asthma,cough,phlegm,persistent or intermittent low-flow oxygen and symptomatic treatment.Treatment group 20 cases in the control group based on the use Shuxuetong intravenous injection,1 / d.After a coures of treatment（15d） to clinical symptoms were observed before and after treatment,signs and laboratory test results to improve the situation.[Results]The treatment group were markedly 8 cases,effective 9 cases,invalid 3 cases,the total markedly rate for 85.00%.The control group were markedly 3 cases,effective 6 cases,invalid 6 cases,the total markedly rate for 60.00%.Clinical efficacy of the treatment group than the control group（P0.05）.[Conclusion]Treating pulmonary interstitial fibrosis with Shuxuetong injection has a good effect.